Interference sequence of IL-17 gene closely related to primary nephrotic syndrome podocyte injury
A primary nephropathy, interfering sequence technology, applied in the field of interfering sequence of IL-17 gene, can solve problems such as renal failure, incompletely understood pathogenesis, unknown etiology, etc., achieve moderate chromatin distribution, alleviate podocyte damage Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0022] Material
[0023] experimental animals
[0024] Male SD rats, 4-5 weeks old, weighing 180-200 g, were purchased from the Shanghai Institute of Zoology, Chinese Academy of Sciences, and randomly divided into a control group (40 rats) and an adriamycin nephropathy model group (80 rats).
[0025] Cells and strains
[0026] 293T cells, E. coli strain DH5α, for helper packaging vector plasmids and amplification of lentiviral plasmid vectors.
[0027] interference sequence
[0028] According to the SD rat IL-17 gene cDNA sequence (Genebank, NM_001106897), use the shRNA target site of the Internet online tool http: / / www.Genesil.com to design the IL-17 interference sequence online, as shown in Table 2, provided by Shanghai Heyuan Biotechnology Ltd. completed.
[0029] Table 2
[0030]
[0031] RNAi lentiviral vector
[0032] Lentiviral plasmid vector (pLKD-CMV-G&PR-U6-shRNA), cut off the ccdB toxic gene downstream of the U6 promoter by double enzyme digestion to form s...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



